Loading company…
Onchilles Pharma develops drug candidates targeting cancer cells.
Founded in 2017 and based in California, Onchilles Pharma develops drug candidates based on ELANE, a proposed treatment approach intended to kill cancer cells regardless of genetic mutation or anatomical origin. It was co-founded by Court R. Turner and Lev Becker. In June 2021, it received Series A backing from Lyzz Capital and UChicago Startup Investment Program.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in